Abstract:To find novel and effective anti-cancer agents, sixteen novel imamine-1,3,5-triazine derivatives were firstly designed and synthesized by molecular hybridization strategy and nucleophilic substitution reaction. The sturcutures of imamine-1,3,5-triazine derivatives were characterized by 1H NMR, 13C NMR, IR, HR-MS and single crystal X-ray diffraction. These compounds were tested using the methyl thiazolyl tetrazolium (MTT) assay for their antiproliferative properties against MDA-MB-231 (breast cancer cell), HeLa (cervical cancer cell) and A498 (kidney cancer cell) with imatinib as the positive control which was the parent compound of imamine. The data revealed that some of the imamine-1,3,5-triazine derivatives possessed better anticancer activity than Imatinib. The imamine-1,3,5-triazine derivatives were selective against triple-negative MDA-MB-231 breast cancer cells. Compound 4f (N2-Allyl-6-chloro-N2-methyl-N4-(4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl) amino) phenyl)-1,3,5-triazine-2,4-diamine) and 4k (6-Chloro-N2-cyclohexyl-N2-methyl-N4-(4-methyl-3-((4-(pyridin-3-yl) pyrimidin-2-yl) amino) phenyl)-1,3,5-triazine-2,4-diamine) demonstrated potent anti-proliferative activity against MDA-MB-231 cells with IC50 of 6.25 μM and 8.18 μM respectively surpassing that of imatinib (IC50 = 35.50 μM). Further studies have shown that compound 4f not only inhibits the migration, invasion, adhesion, and proliferation of MDA-MB-231 cells, but also has a strong inhibitory effect on the proliferation of MDA-MB-231 tumor xenografts in vivo. In addition, the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties prediction suggest that these compounds may have the properties of drug candidates. Thus, compound 4f may be a promising drug candidate for the treatment of cancer.

Design and synthesis of N-(1-(6-(substituted phenyl)-pyridazin-3-yl)-piperidine-3-yl)-amine derivatives as JMJD6 inhibitors

Design, synthesis and biological evaluation of pyrimidine base hydroxamic acid derivatives as dual JMJD3 and HDAC inhibitors

Identification of a new class of natural product MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities and target validation.

Synthesis and biological evaluation of 4,6-diaryl-2-pyrimidinamine derivatives as anti-breast cancer agents.

Novel 5-Carboxy-8-hq Based Histone Demethylase JMJD2A Inhibitors: Introduction of an Additional Carboxyl Group at the C-2 Position of Quinoline.

Design, Synthesis and Biological Evaluation of Jahanyne Analogs As Cell Cycle Arrest Inducers

Design, synthesis, and evaluation of benzodioxolane compounds for antitumor activity

Design,Synthesis and Anti-cervical Cancer Activity of Piperine-bicycloamide Derivatives

Discovery of a New Class of JMJD6 Inhibitors and Structure–activity Relationship Study

Discovery of Pyrimidinediamine Derivatives as Potent Methuosis Inducers for the Treatment of Triple-Negative Breast Cancer

Design, Synthesis and Biological Evaluation of Novel Antitumor Spirotetrahydrothiopyran-Oxindole Derivatives As Potent P53-Mdm2 Inhibitors

Discovery of Piperazin‐2‐yl‐pyrimidines as Anticancer Agents via Targeting JNK Signaling Pathway in Human MCF‐7 Breast Carcinoma

Design, Synthesis and Biological Evaluation of Piperine Derivatives As Potent Antitumor Agents

Design, Synthesis, and Anticancer Evaluation of Nitrobenzoxadiazole-Piperazine Hybrids As Potent Pro-Apoptotic Agents

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.

Discovery of 5-(Pyrimidin-2-ylamino)-1h-indole-2-carboxamide Derivatives As Nur77 Modulators with Selective and Potent Activity Against Triple-Negative Breast Cancer.

Structurally diverse design and synthesis of novel 2-phenylindole amide derivatives with anti-canine breast cancer activity

Design, Synthesis, and Biological Evaluation of Pyrido[2,3-d]pyrimidin-7(8H)-one Derivatives As Potent USP1 Inhibitors

Design, synthesis, and biological evaluation of quinazolin-4(3H)-one derivatives co-targeting poly(ADP-ribose) polymerase-1 and bromodomain containing protein 4 for breast cancer therapy

Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer

Design, Synthesis and Anticancer evaluation of Imamine-1,3,5-triazine derivatives